- News
1 August 2019
Riber’s first-half revenue falls 17% year-on-year
Riber S.A. of Bezons, France – which manufactures molecular beam epitaxy (MBE) systems as well as evaporation sources and effusion cells – has reported revenues of €13.9m for first-half 2019, down 17% from first-half 2018’s €16.7m.
Evaporator revenue has plummeted by 90% from €10.4m to €1m due to the freeze in investments in organic light-emitting diode (OLED) screen production equipment (following the major investments made in previous years).
System revenue has more than doubled, rising by 132% from €3.7m to €8.6m, reflecting this activity’s robust development. Four production systems were delivered, compared with just one production system and three research systems in first-half 2018.
Services & Accessories revenue rose by 65% from €2.6m to €4.3m, in line with the development strategy for this strong contributive business.
Corresponding to the strong cyclical decline in evaporator sales, the proportion of total revenue from Asia has fallen from 74% to 22%, while Europe has risen from 20% to 56% and the USA from just 6% to 22%.
The order book at end-June has fallen year-on-year by 17% from €34.3m to €28.4m. However, this is largely due to Evaporator orders falling from €3.8m to zero. Services & Accessories orders fell by 17% from €8.3m to €6.9m, while Systems orders were down by just 3% from €22.2m to €21.5m. The latter comprised 13 systems including six production units.
Riber says that, considering the still healthy level of the order book (including a large number of systems to be delivered in 2019), it is forecasting year-on-year growth in revenue for full-year 2019.
Riber’s Q1 revenue falls 10% year-on-year as weak evaporator sales outweigh MBE system sales growth
Riber grows annual revenue by 2.3% to another record of €31.3m
Riber’s first-half revenue grows 36% year-on-year as MBE system sales quadruple